Knoll Capital Management as of Sept. 30, 2019
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 23 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding | 32.7 | $36M | 858k | 41.72 | |
| Corbus Pharmaceuticals Hldgs | 22.2 | $24M | 5.0M | 4.87 | |
| Blackstone | 6.8 | $7.5M | 153k | 48.84 | |
| Abeona Therapeutics | 4.9 | $5.3M | 2.4M | 2.26 | |
| Applied Therapeutics (APLT) | 4.7 | $5.1M | 467k | 10.99 | |
| Krystal Biotech (KRYS) | 3.8 | $4.2M | 120k | 34.72 | |
| Altria (MO) | 3.4 | $3.7M | 90k | 40.90 | |
| Eiger Biopharmaceuticals | 3.3 | $3.6M | 350k | 10.25 | |
| Kranesh Bosera Msci China A cmn (KBA) | 2.6 | $2.9M | 96k | 29.90 | |
| Aldeyra Therapeutics (ALDX) | 2.6 | $2.8M | 532k | 5.27 | |
| CenturyLink | 2.5 | $2.7M | 220k | 12.48 | |
| Anavex Life Sciences (AVXL) | 2.1 | $2.3M | 724k | 3.16 | |
| Dupont De Nemours (DD) | 2.0 | $2.1M | 30k | 71.30 | |
| Dow (DOW) | 1.3 | $1.4M | 30k | 47.67 | |
| Entera Bio (ENTX) | 1.1 | $1.2M | 476k | 2.49 | |
| Corteva (CTVA) | 0.8 | $840k | 30k | 28.00 | |
| Molecular Templates | 0.7 | $751k | 114k | 6.59 | |
| Soligenix | 0.7 | $748k | 788k | 0.95 | |
| Galmed Pharmaceuticals | 0.6 | $696k | 146k | 4.78 | |
| Catasys | 0.6 | $678k | 43k | 15.75 | |
| Electrocore | 0.4 | $482k | 220k | 2.19 | |
| Lipocine | 0.1 | $141k | 50k | 2.82 | |
| Vascular Biogenics | 0.0 | $29k | 21k | 1.36 |
